Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement

Clinical trial NCT01094886 · COMPLETED

Trial details

NCT number: NCT01094886
Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis Osteoarthritis, Knee Osteoarthritis, Hip Thromboembolism

Start date: 2010-03-01
Primary completion: 2010-12-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.